UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report Pursuant
to
Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (Date of earliest event reported)
November 13, 2006
PRESSURE
BIOSCIENCES, INC.
|
(Exact
Name of Registrant as Specified in its Charter)
|
|
MASSACHUSETTS
|
(State
or Other Jurisdiction of
Incorporation)
|
0-21615
|
|
04-2652826
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification No.)
|
321
Manley Street, West Bridgewater, MA
|
|
02379
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(508)
580-1818
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
N/A
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02 Results
of Operations and Financial Condition
On
November 13, 2006, the Company issued a press release announcing its financial
results for the third quarter ended September 30, 2006. A copy of the press
release is attached hereto as Exhibit 99.1 and is incorporated herein in
its entirety by reference.
Limitation
on Incorporation by Reference. The
information furnished in this Item 2.02 shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that section, nor shall such information
be deemed incorporated by reference in any filing under the Securities Act
of
1933, as amended, except as shall be expressly set forth by specific reference
in such a filing.
Cautionary
Note Regarding Forward-Looking Statements. Except
for historical information contained in the press release attached as an exhibit
hereto, the press release contains forward-looking statements which involve
certain risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by these statements. Please refer
to
the cautionary note in the press release regarding these forward-looking
statements.
Item
9.01 Financial
Statements and Exhibits
Exhibit
Number
|
Exhibit
Description
|
99.1
|
Press
release dated November 13, 2006 of Pressure BioSciences, Inc. announcing
its financial results for the third quarter ended September 30,
2006.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this Report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
Dated:
November 13, 2006 |
PRESSURE
BIOSCIENCES, INC. |
|
|
|
|
By: |
/s/
Richard T. Schumacher |
|
Richard
T. Schumacher, President and Chief Executive
Officer
|
|
|
EXHIBIT
INDEX
Exhibit
Number
|
Exhibit
Description
|
99.1
|
Press
release dated November 13, 2006 of Pressure BioSciences, Inc. announcing
its financial results for the third quarter ended September 30,
2006.
|